Vanderbilt researchers have made the surprising discovery that the protease plasmin, known for its clot-busting role in the blood, protects soft tissue from turning to bone after severe injuries and certain orthopaedic surgeries.

A new microfluidic device containing human cells that faithfully mimics the behavior of the blood-brain barrier is providing new insights into brain inflammation, the silent killer.

Vanderbilt University School of Medicine (VUSM) has formed a new Basic Science Research Advisory Committee.

Researchers at Vanderbilt University Medical Center (VUMC) are leading a multicenter clinical trial to evaluate whether a shorter course of antibiotics — five days instead of 10 — is effective at treating community-acquired pneumonia (CAP) in children who show improvement after the first few days of taking antibiotics.

Elaine Fuchs, Ph.D., whose innovative use of reverse genetics has helped redefine the study of skin diseases and cancer stem cells, is the recipient of the 2016 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center (VUMC) announced today.

Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.

Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk.